By HAYWARD, Calif., Jan. 4, 2012/PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the 14th Annual Needham Growth Conference at the New York Palace Hotel in New York Cityon Thursday, January 12, 2012at 10:00 am Eastern Time. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company's business strategy and recent corporate events.
Attendance at this conference is by invitation only. Solta will offer a live audio webcast of its presentation which may be accessed at the Investor Relations section of the Company's website at . An archived replay of the presentation will be available for 15 days, also at .
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical
aesthetics market providing innovative, safe, and effective
solutions for patients that enhance and expand the practice
of medical aesthetics for physicians. The company offers
products to address a range of skin issues under the
industry´s six premier brands: Thermage®, Fraxel®,
liposonix®, Isolaz®, CLARO® and Clear + Brilliant®.
Thermage is an innovative, non-invasive radiofrequency
procedure for tightening and contouring skin. As the leader
in fractional laser technology, Fraxel delivers minimally
invasive clinical solutions to resurface aging and sun
damaged skin. The liposonix system uses advanced
high-intensity focused ultrasound (HIFU) technology to
permanently destroy targeted fat just beneath the skin in
the treatment areas of the abdomen and flanks as a
noninvasive, nonsurgical approach to aesthetic waist
circumference reduction. Isolaz was the first laser or
light based system indicated for the treatment of
inflammatory acne, comedonal acne, pustular acne, and
mild-to-moderate inflammatory acne. CLARO is a personal
care acne system that is the first FDA cleared
over-the-counter IPL device that uses a powerful
combination of both heat and light to clear skin quickly
and naturally. Clear + Brilliant is a unique,
cost-effective treatment that utilizes safe, fractional
laser technology to correct and prevent early signs of
aging and is FDA cleared and CE marked. Since 2002, over
one million Thermage, Fraxel and Isolaz procedures have
been performed in over 100 countries.Solta Medical.
SOURCE Solta Medical, Inc.
Jack Glenn Chief Financial Officer, +1-510-786-6890 or Doug Sherk/Jenifer Kirtland of EVC Group, +1- 415-568-4887
| distribué par | Ce noodl a été diffusé par Solta Medical Inc. et initialement mise en ligne sur le site http://www.solta.com. La version originale est disponible ici. Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-04 22:33:10 PM et restera accessible depuis ce lien permanent. Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité. |
